# GlycanAge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glycanage

- Industry: Healthcare
- Headquarters: Newcastle upon Tyne, UK
- Website: www.glycanage.com
- Total disclosed funding: $4.4M
- Latest round: Seed (Dec 22, 2023)
- Investors on record: 2

## About

Based in Newcastle upon Tyne, UK, and founded in 2019 by co-founder and CEO Nikolina Lauc, GlycanAge Ltd operates as a developer of biological age tests that allow users to discover, measure, and optimize longevity. In December 2025, GlycanAge Ltd raised GBP 6.5 million in venture funding led by Fifth Quarter Ventures, with participation from BrightCap Ventures, South Central Ventures, Impetus Capital, Vesna Venture Capital, Lightfield Equity, Guinness Global Investors, LAUNCHub, AND Kadmos Capital. The company plans to utilize the December 2025 funding to speed up the creation of clinical applications, confirm diagnostic uses, and grow its partnerships with hospitals and laboratory facilities on a global scale.

## Funding rounds

- Seed, Dec 22, 2023, $4.4M — LAUNCHub, Kadmos Capital

## Investors

- LAUNCHub (https://capitalatlas.ai/funds/launchub) — Seed
- Kadmos Capital (https://capitalatlas.ai/funds/kadmos-capital) — Seed